Chase Knickerbocker
Stock Analyst at Craig-Hallum
(3.47)
# 837
Out of 4,829 analysts
36
Total ratings
48.57%
Success rate
5.5%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals | Maintains: Buy | $23 → $26 | $16.86 | +54.21% | 5 | Mar 19, 2025 | |
| XERS Xeris Biopharma Holdings | Maintains: Buy | $5 → $6.5 | $5.01 | +29.74% | 1 | Mar 7, 2025 | |
| MDWD MediWound | Initiates: Buy | $39 | $17.46 | +123.37% | 1 | Feb 28, 2025 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Buy | $10 → $8 | $0.71 | +1,028.03% | 4 | Jan 22, 2025 | |
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $14.84 | +41.51% | 2 | Jan 17, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $5 → $6 | $3.13 | +91.69% | 2 | Jan 17, 2025 | |
| SCPH scPharmaceuticals | Maintains: Buy | $16 → $12 | $2.44 | +391.80% | 2 | Nov 14, 2024 | |
| PYPD PolyPid | Initiates: Buy | $10 | $2.78 | +259.71% | 1 | Nov 4, 2024 | |
| INDV Indivior | Maintains: Buy | $20 → $16 | $11.08 | +44.40% | 3 | Oct 11, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $65 | $24.40 | +166.39% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $15 | $5.95 | +152.10% | 4 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $7.05 | +70.21% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.19 | +22.10% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $9.39 | +144.94% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.50 | +137.79% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $3.14 | +568.79% | 1 | Mar 13, 2023 |
Eton Pharmaceuticals
Mar 19, 2025
Maintains: Buy
Price Target: $23 → $26
Current: $16.86
Upside: +54.21%
Xeris Biopharma Holdings
Mar 7, 2025
Maintains: Buy
Price Target: $5 → $6.5
Current: $5.01
Upside: +29.74%
MediWound
Feb 28, 2025
Initiates: Buy
Price Target: $39
Current: $17.46
Upside: +123.37%
Ironwood Pharmaceuticals
Jan 22, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $0.71
Upside: +1,028.03%
Delcath Systems
Jan 17, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $14.84
Upside: +41.51%
KORU Medical Systems
Jan 17, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $3.13
Upside: +91.69%
scPharmaceuticals
Nov 14, 2024
Maintains: Buy
Price Target: $16 → $12
Current: $2.44
Upside: +391.80%
PolyPid
Nov 4, 2024
Initiates: Buy
Price Target: $10
Current: $2.78
Upside: +259.71%
Indivior
Oct 11, 2024
Maintains: Buy
Price Target: $20 → $16
Current: $11.08
Upside: +44.40%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $65
Current: $24.40
Upside: +166.39%
Aug 14, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $5.95
Upside: +152.10%
Aug 1, 2024
Maintains: Buy
Price Target: $14 → $12
Current: $7.05
Upside: +70.21%
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $8.19
Upside: +22.10%
May 9, 2024
Maintains: Buy
Price Target: $22 → $23
Current: $9.39
Upside: +144.94%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.50
Upside: +137.79%
Mar 13, 2023
Initiates: Buy
Price Target: $21
Current: $3.14
Upside: +568.79%